Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis

ACS Nano

Volumn 7, Issue 10, 2013, Pages 9001-9009

  Lin, Kevin Y ^a   Kwong, Gabriel A ^a,b   Warren, Andrew D ^a,b   Wood, David K ^a,b,c   Bhatia, Sangeeta N ^a,b,d,e  

^a USA   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c University of Minnesota   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

nanoparticles; peptides; synthetic biomarkers; thrombin; urinary diagnostic

Indexed keywords

PEPTIDE SUBSTRATES; POINT-OF-CARE DIAGNOSTICS; PULMONARY EMBOLISM; SERINE PROTEASE; THROMBIN; URINARY BIOMARKERS; URINARY DIAGNOSTIC; VASCULAR DISEASE;

AMINO ACIDS; BIOMARKERS; BODY FLUIDS; DIAGNOSIS; DISEASES; LIGANDS; NANOPARTICLES; PEPTIDES; SUBSTRATES;

ENZYMES;

BIOLOGICAL MARKER; LIGAND; NANOPARTICLE; THROMBOPLASTIN;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; ENZYME LINKED IMMUNOSORBENT ASSAY; LUNG EMBOLISM; MOUSE; THROMBOSIS; URINE;

ANIMALS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; LIGANDS; MICE; NANOPARTICLES; PULMONARY EMBOLISM; THROMBOPLASTIN; THROMBOSIS;

EID: 84887001117     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn403550c     Document Type: Article

References (63)

1. Pisitkun, T.; Johnstone, R.; Knepper, M. A. Discovery of Urinary Biomarkers Mol. Cell. Proteomics 2006, 5, 1760-1771
2. Barratt, J.; Topham, P. Urine Proteomics: The Present and Future of Measuring Urinary Protein Components in Disease Can. Med. Assoc. J. 2007, 177, 361-368
3. Adachi, J.; Kumar, C.; Zhang, Y.; Olsen, J. V.; Mann, M. The Human Urinary Proteome Contains More than 1500 Proteins, Including a Large Proportion of Membrane Proteins Genome Biol. 2006, 7, R80
4. Wide, L.; Gemzell, C. A. An Immunological Pregnancy Test Acta Endrocrinol. 1960, XXXV, 261-267
5. Cole, L. A.; Kardana, A.; Seifer, D. B.; Bohler, H. C. Urine hCG Beta-Subunit Core Fragment, a Sensitive Test for Ectopic Pregnancy J. Clin. Endocrinol. Metab. 1994, 78, 497-499
6. Hinokio, Y.; Suzuki, S.; Hirai, M.; Chiba, M.; Hirai, A.; Toyota, T. Oxidative DNA Damage in Diabetes Mellitus: Its Association with Diabetic Complications Diabetologia 1999, 42, 995-998
7. Nishikawa, T.; Sasahara, T.; Kiritoshi, S.; Sonoda, K.; Senokuchi, T.; Matsuo, T.; Kukidome, D.; Wake, N.; Matsumura, T.; Miyamura, N. et al. Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Diabetes Care 2003, 26, 1507-1512
8. Wu, L. L.; Chiou, C. C.; Chang, P. Y.; Wu, J. T. Urinary 8-OHdG: A Marker of Oxidative Stress to DNA and a Risk Factor for Cancer, Atherosclerosis and Diabetics Clin. Chim. Acta 2004, 339, 1-9
9. Rossing, K.; Mischak, H.; Dakna, M.; Zürbig, P.; Novak, J.; Julian, B. A.; Good, D. M.; Coon, J. J.; Tarnow, L.; Rossing, P. Urinary Proteomics in Diabetes and CKD J. Am. Soc. Nephrol. 2008, 19, 1283-1290
10. Tesch, G. H. Review: Serum and Urine Biomarkers of Kidney Disease: A Pathophysiological Perspective Nephrology 2010, 15, 609-616
11. Fassett, R. G.; Venuthurupalli, S. K.; Gobe, G. C.; Coombes, J. S.; Cooper, M. A.; Hoy, W. E. Biomarkers in Chronic Kidney Disease: A Review Kidney Int. 2011, 80, 806-821
12. Mishra, J.; Ma, Q.; Prada, A.; Mitsnefes, M.; Zahedi, K.; Yang, J.; Barasch, J.; Devarajan, P. Identification of Neutrophil Gelatinase-Associated Lipocalin as a Novel Early Urinary Biomarker for Ischemic Renal Injury J. Am. Soc. Nephrol. 2003, 14, 2534-2543
13. Isomaa, B.; Almgren, P.; Tuomi, T.; Forsén, B.; Lahti, K.; Nissén, M.; Taskinen, M.-R.; Groop, L. Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome Diabetes Care 2001, 24, 683-689
14. Palaniappan, L.; Carnethon, M.; Fortmann, S. P. Association Between Microalbuminuria and the Metabolic Syndrome: NHANES III Am. J. Hypertens. 2003, 16, 952-958
15. Moses, M. A.; Wiederschain, D.; Loughlin, K. R.; Zurakowski, D.; Lamb, C. C.; Freeman, M. R. Increased Incidence of Matrix Metalloproteinases in Urine of Cancer Patients Cancer Res. 1998, 58, 1395-1399
16. Roy, R.; Yang, J.; Moses, M. A. Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer J. Clin. Oncol. 2009, 27, 5287-5297
17. Kwong, G. A.; von Maltzahn, G.; Murugappan, G.; Abudayyeh, O.; Mo, S.; Papayannopoulos, I. A.; Sverdlov, D. Y.; Liu, S. B.; Warren, A. D.; Popov, Y. et al. Mass-Encoded Synthetic Biomarkers for Multiplexed Urinary Monitoring of Disease Nat. Biotechnol. 2013, 31, 63-70
18. Robbins, S. L.; Kumar, V.; Cotran, R. S. Robbins and Cotran Pathologic Basis of Disease; Saunders/Elsevier: Philadelphia, 2010.
19. Davie, E. W.; Kulman, J. D. An Overview of the Structure and Function of Thrombin Semin. Thromb. Hemostasis 2006, 32, 003-015
20. Huntington, J. A. Molecular Recognition Mechanisms of Thrombin Semin. Thromb. Hemostasis 2005, 3, 1861-1872
21. Jaffer, F. A.; Tung, C.-H.; Gerszten, R. E.; Weissleder, R. In Vivo Imaging of Thrombin Activity in Experimental Thrombi With Thrombin-Sensitive Near-Infrared Molecular Probe Arterioscler., Thromb., Vasc. Biol. 2002, 22, 1929-1935
22. Tung, C.-H.; Gerszten, R. E.; Jaffer, F. A.; Weissleder, R. A Novel Near-Infrared Fluorescence Sensor for Detection of Thrombin Activation in Blood ChemBioChem 2002, 3, 207-211
23. Olson, E. S.; Whitney, M. A.; Friedman, B.; Aguilera, T. A.; Crisp, J. L.; Baik, F. M.; Jiang, T.; Baird, S. M.; Tsimikas, S.; Tsien, R. Y. et al. In Vivo Fluorescence Imaging of Atherosclerotic Plaques with Activatable Cell-Penetrating Peptides Targeting Thrombin Activity Integr. Biol. 2012, 4, 595-605
24. Whitney, M.; Savariar, E. N.; Friedman, B.; Levin, R. A.; Crisp, J. L.; Glasgow, H. L.; Lefkowitz, R.; Adams, S. R.; Steinbach, P.; Nashi, N. et al. Ratiometric Activatable Cell-Penetrating Peptides Provide Rapid in Vivo Readout of Thrombin Activation Angew. Chem., Int. Ed. 2013, 52, 325-330
25. Bounameaux, H.; de Moerloose, P.; Perrier, A.; Reber, G. Plasma Measurement of D-Dimer as Diagnostic Aid in Suspected Venous Thromboembolism: An Overview Thromb. Haemostasis 1994, 71, 1-6
26. Ginsberg, J. S.; Wells, P. S.; Kearon, C.; Anderson, D.; Crowther, M.; Weitz, J. I.; Bormanis, J.; Brill-Edwards, P.; Turpie, A. G.; MacKinnon, B. et al. Sensitivity and Specificity of a Rapid Whole-Blood Assay for D-Dimer in the Diagnosis of Pulmonary Embolism Ann. Intern. Med. 1998, 129, 1006-1011
27. Becker, R. C.; Spencer, F. A. Thrombin: Structure, Biochemistry, Measurement, and Status in Clinical Medicine J. Thromb. Thrombolysis 1998, 5, 215-229
28. Choi, H. S.; Liu, W.; Misra, P.; Tanaka, E.; Zimmer, J. P.; Itty Ipe, B.; Bawendi, M. G.; Frangioni, J. V. Renal Clearance of Quantum Dots Nat. Biotechnol. 2007, 25, 1165-1170
29. Park, J.-H.; Maltzahn, G. v.; Zhang, L.; Schwartz, M. P.; Ruoslahti, E.; Bhatia, S. N.; Sailor, M. J. Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging Adv. Mater. 2008, 20, 1630-1635
30. Park, J.-H.; von Maltzahn, G.; Zhang, L.; Derfus, A. M.; Simberg, D.; Harris, T. J.; Ruoslahti, E.; Bhatia, S. N.; Sailor, M. J. Systematic Surface Engineering of Magnetic Nanoworms for in Vivo Tumor Targeting Small 2009, 5, 694-700
31. Mitchell, G. A.; Gargiulo, R. J.; Huseby, R. M.; Lawson, D. E.; Pochron, S. P.; Sehuanes, J. A. Assay for Plasma Heparin Using a Synthetic Peptide Substrate for Thrombin: Introduction of the Fluorophore Aminoisophthalic Acid, Dimethyl Ester Thromb. Res. 1978, 13, 47-52
32. Asai, K.; Asai, M. A Colorimetric Assay for Plasma Antithrombin III Using a New Synthetic Peptide Substrate (PS-915) Clin. Chim. Acta 1984, 144, 163-171
33. Larsen, M. L.; Abildgaard, U.; Teien, A. N.; Gjesdal, K. Assay of Plasma Heparin Using Thrombin and the Chromogenic Substrate H-D-Phe-Pip-Arg-pNA (S-2238) Thromb. Res. 1978, 13, 285-288
34. Rijkers, D. S.; Wielders, S. J. H.; Tesser, G. I.; Hemker, H. C. Design and Synthesis of Thrombin Substrates with Modified Kinetic Parameters Thromb. Res. 1995, 79, 491-499
35. Morris, T. A.; Marsh, J. J.; Burrows, C. M.; Chiles, P. G.; Konopka, R. G.; Pedersen, C. A. Urine and Plasma Levels of Fibrinopeptide B in Patients with Deep Vein Thrombosis and Pulmonary Embolism Thromb. Res. 2003, 110, 159-165
36. Rosi, N. L.; Mirkin, C. A. Nanostructures in Biodiagnostics Chem. Rev. 2005, 105, 1547-1562
37. Weiss, E. J.; Hamilton, J. R.; Lease, K. E.; Coughlin, S. R. Protection Against Thrombosis in Mice Lacking PAR3 Blood 2002, 100, 3240-3244
38. Lenain, N.; Freund, M.; Léon, C.; Cazenave, J. P.; Gachet, C. Inhibition of Localized Thrombosis in P2Y1-Deficient Mice and Rodents Treated with MRS2179, a P2Y1 Receptor Antagonist Semin. Thromb. Hemostasis 2003, 1, 1144-1149
39. Smyth, S. S.; Reis, E. D.; Väänänen, H.; Zhang, W.; Coller, B. S. Variable Protection of β3-Integrin-Deficient Mice from Thrombosis Initiated by Different Mechanisms Blood 2001, 98, 1055-1062
40. Mackman, N. Triggers, Targets and Treatments for Thrombosis Nature 2008, 451, 914-918
41. Koeppen, B. M.; Stanton, B. A. Renal Physiology; Mosby Elsevier: Philadelphia, 2007.
42. Vestergaard, P.; Leverett, R. Constancy of Urinary Creatinine Excretion J. Lab. Clin. Med. 1958, 51, 211-218
43. Wyss, M.; Kaddurah-Daouk, R. Creatine and Creatinine Metabolism Physiol. Rev. 2000, 80, 1107-1213
44. Roe, J. H.; Epstein, J. H.; Goldstein, N. P. A Photometric Method for the Determination of Inulin in Plasma and Urine J. Biol. Chem. 1949, 178, 839-845
45. Gaspari, F.; Perico, N.; Remuzzi, G. Measurement of Glomerular Filtration Rate Kidney Int., Suppl. 1997, 63, S151-S154
46. Qi, Z.; Whitt, I.; Mehta, A.; Jin, J.; Zhao, M.; Harris, R. C.; Fogo, A. B.; Breyer, M. D. Serial Determination of Glomerular Filtration Rate in Conscious Mice Using FITC-Inulin Clearance Am. J. Physiol.:Renal, Fluid Electrolyte Physiol. 2004, 286, F590-F596
47. Ghadiali, J. E.; Stevens, M. M. Enzyme-Responsive Nanoparticle Systems Adv. Mater. 2008, 20, 4359-4363
48. Welser, K.; Adsley, R.; Moore, B. M.; Chan, W. C.; Aylott, J. W. Protease Sensing with Nanoparticle Based Platforms Analyst 2011, 136, 29-41
49. de la Rica, R.; Aili, D.; Stevens, M. M. Enzyme-Responsive Nanoparticles for Drug Release and Diagnostics Adv. Drug Delivery Rev. 2012, 64, 967-978
50. Frangioni, J. V. In Vivo Near-Infrared Fluorescence Imaging Curr. Opin. Chem. Biol. 2003, 7, 626-634
51. Yager, P.; Domingo, G. J.; Gerdes, J. Point-of-Care Diagnostics for Global Health Ann. Rev. Biomed. Eng. 2008, 10, 107-144
52. Martinez, A. W.; Phillips, S. T.; Whitesides, G. M.; Carrilho, E. Diagnostics for the Developing World: Microfluidic Paper-Based Analytical Devices Anal. Chem. 2009, 82, 3-10
53. Warren, A. D.; Kwong, G. A.; Wood, D. K.; Lin, K. Y.; Bhatia, S. N. Point-of-Care Diagnostics for Non-Communicable Diseases Using Synthetic Urinary Biomarkers and Paper Microfluidics. Unpublished work.
54. Backes, B. J.; Harris, J. L.; Leonetti, F.; Craik, C. S.; Ellman, J. A. Synthesis of Positional-scanning Libraries of Fluorogenic Peptide Substrates to Define the Extended Substrate Specificity of Plasmin and Thrombin Nat. Biotechnol. 2000, 18, 187-193
55. Botnar, R. M.; Perez, A. S.; Witte, S.; Wiethoff, A. J.; Laredo, J.; Hamilton, J.; Quist, W.; Parsons, E. C.; Vaidya, A.; Kolodziej, A. et al. In Vivo Molecular Imaging of Acute and Subacute Thrombosis Using a Fibrin-Binding Magnetic Resonance Imaging Contrast Agent Circulation 2004, 109, 2023-2029
56. Simberg, D.; Duza, T.; Park, J. H.; Essler, M.; Pilch, J.; Zhang, L.; Derfus, A. M.; Yang, M.; Hoffman, R. M.; Bhatia, S. et al. Biomimetic Amplification of Nanoparticle Homing to Tumors Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 932-936
57. Hara, T.; Bhayana, B.; Thompson, B.; Kessinger, C. W.; Khatri, A.; McCarthy, J. R.; Weissleder, R.; Lin, C. P.; Tearney, G. J.; Jaffer, F. A. Molecular Imaging of Fibrin Deposition in Deep Vein Thrombosis Using Fibrin-targeted Near-Infrared Fluorescence J. Am. Coll. Cardiol.: Cardiovasc. Imaging 2012, 5, 607-615
58. Imai, Y.; Murakami, T.; Yoshida, S.; Nishikawa, M.; Ohsawa, M.; Tokunaga, K.; Murata, M.; Shibata, K.; Zushi, S.; Kurokawa, M. et al. Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Images of Hepatocellular Carcinoma: Correlation with Histological Grading Hepatology 2000, 32, 205-212
59. Reimer, P.; Jähnke, N.; Fiebich, M.; Schima, W.; Deckers, F.; Marx, C.; Holzknecht, N.; Saini, S. Hepatic Lesion Detection and Characterization: Value of Nonenhanced MR Imaging, Superparamagnetic Iron Oxide-Enhanced MR Imaging, and Spiral CT-ROC Analysis Radiology 2000, 217, 152-158
60. Harisinghani, M. G.; Barentsz, J.; Hahn, P. F.; Deserno, W. M.; Tabatabaei, S.; van de Kaa, C. H.; de la Rosette, J.; Weissleder, R. Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer N. Engl. J. Med. 2003, 348, 2491-2499
61. Reimer, P.; Balzer, T. Ferucarbotran (Resovist): A New Clinically Approved RES-Specific Contrast Agent for Contrast-Enhanced MRI of the Liver: Properties, Clinical Development, and Applications Eur. Radiol. 2003, 13, 1266-1276
62. Tanimoto, A.; Kuribayashi, S. Application of Superparamagnetic Iron Oxide to Imaging of Hepatocellular Carcinoma Eur. J. Radiol. 2006, 58, 200-216
63. Heesakkers, R. A. M.; Jager, G. J.; Hövels, A. M.; de Hoop, B.; van den Bosch, H. C. M.; Raat, F.; Witjes, J. A.; Mulders, P. F. A.; van der Kaa, C. H.; Barentsz, J. O. Prostate Cancer: Detection of Lymph Node Metastases Outside the Routine Surgical Area with Ferumoxtran-10-Enhanced MR Imaging Radiology 2009, 251, 408-414